Hyundai Motor India: Q1 FY27 Revenue at ₹163,346 Mn., PAT at ₹8,886 Mn.

Hyundai Motor India Limited (HMIL) announced its unaudited standalone and consolidated financial results for the first quarter of FY 2026-27. The company reported a revenue of INR 163,346 Mn. and a Profit After Tax (PAT) of INR 8,886 Mn. The results reflect a challenging quarter impacted by headwinds, though the company remains committed to its full-year guidance.

Hyundai Motor India Reports Q1 FY27 Financial Snapshot

Hyundai Motor India Limited (HMIL) has released its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved the results, showing a revenue of INR 163,346 Mn. and a Profit After Tax (PAT) of INR 8,886 Mn.

Key Highlights for Q1 FY27

The first quarter was marked by several key developments:

  • The company is celebrating 30 years in India, reflecting a long-standing presence in the market.
  • The all-new Venue recorded its highest-ever quarterly sales in the domestic market, indicating strong customer traction.
  • CNG offerings showed increased contribution, with Aura and Exter reaching their highest-ever CNG contributions at 95% and 32% respectively.
  • Rural market penetration reached an all-time high of 26%.
  • Temporary production disruptions led to a limited domestic volume growth of 5.4% YoY, while exports were impacted by the West Asia conflict.

Consolidated Financial Performance Snapshot

The consolidated financial snapshot for the quarter is as follows:

Particulars Q1 FY27 Q4 FY26 Q1 FY26 Annual FY26
Revenue 163,346 189,162 164,129 707,633
EBITDA* 15,117 19,660 21,852 85,985
EBITDA % 9.3% 10.4% 13.3% 12.2%
PAT 8,886 12,556 13,692 54,315

*EBITDA excludes other income.

Management Commentary and Outlook

Mr. Tarun Garg, Managing Director & Chief Executive Officer, commented on the results: “Q1 FY27 was a challenging quarter affected by multiple headwinds impacting volumes and profitability. With 100% normalization of production, coupled with healthy demand environment and upcoming product pipeline, recovery is likely to gain pace from Q2 onwards across both domestic and export businesses.”

Looking ahead, HMIL remains committed to achieving its stated guidance of 8-10% (YoY) volume growth for both domestic and exports, and an 11-14% EBITDA margin in FY27.

Source: BSE

Previous Article

Swiggy: Q2 FY27 Consolidated Loss Widens to ₹792 Crore on ₹6,812 Crore Revenue

Next Article

Mankind Pharma: Q1 FY27 Revenue Up 13%, EBITDA Margins Improve